ICOS and neoplasm: Similar to other findings [14], our results showed that in both tumor and spleen, the majority of the Treg population was CD4+foxp3+ICOS+ (approximately 65%) in the Panc02 tumor model, suggesting that CD4+foxp3+ICOS+ Tregs plays a critical suppressive role to the immune system that benefits tumor growth.